You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cancer
  5. Renal cancer

Kidney cancer: diagnosis and management

  • NICE guideline
  • Reference number: NG256
  • Published:  19 March 2026
  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History

On this page

  1. Summary versions
  2. Resource impact
  3. Audit and service improvement
  4. Guidance into practice

Tools and resources

Tools and resources to help you put the guidance into practice.

Summary versions

  • Diagnosis and management of renal cell carcinoma (overview of the guideline) (PDF 261 KB)

    Published:
    19 March 2026
  • Management of localised renal cell carcinoma (PDF 227 KB)

    Published:
    19 March 2026
  • Diagnosis and management of renal cell carcinoma (RCC) in people with a heritable RCC predisposition syndrome (PDF 296 KB)

    Published:
    19 March 2026
  • Systemic anticancer therapy options for advanced renal cell carcinoma (intermediate or poor risk IMDC) (PDF 214 KB)

    Published:
    19 March 2026
  • Systemic anticancer therapy options for advanced renal cell carcinoma (favourable risk IMDC) (PDF 119 KB)

    Published:
    19 March 2026
  • Systemic anticancer therapy options for advanced renal cell carcinoma (intermediate or poor risk IMDC) accessible summary (Word 35 KB)

    Published:
    19 March 2026
  • Systemic anticancer therapy options for advanced renal cell carcinoma (favourable risk IMDC) accessible summary (Word 36 KB)

    Published:
    19 March 2026

Resource impact

  • Resource impact summary report

  • Resource impact template (Excel 2.3 MB)

    Published:
    19 March 2026

Audit and service improvement

  • Baseline assessment tool (Excel 70 KB)

    Published:
    19 March 2026

Guidance into practice

  • About the Into practice guide

  • Practical steps to improving the quality of care and services using NICE guidance

Back to top